NMNeethu K. M.

Neethu K. M.

*This is an algorithmically generated author record based on publicly available information.

Neethu K. M. has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nucleotide Driven Hierarchical Self‐Assembly of Covalent Organic Framework and Gold Nanostar for Molecular Diagnosis of Turner Syndrome

    by Neethu K M, Paresh Mohanty, Neelam, Gunjan Verma, Sugam Kumar, Rijo Rajeev, Chiranjit Bose, Chinmay Saha, Sunetra Mondal, Nitai P Bhattacharrya, et al.

    Turner Syndrome (TS), a rare chromosomal disorder, cause significant phenotypical changes like growth failure and primary ovarian insufficiency. Chromosomal karyotyping, the preferred diagnostic method till date, resulting in delayed diagnosis that precludes early intervention. Hence, there is a clear unmet clinical need for rapid and cost‐effective diagnostic tool for TS. The current study focuses on developing a multiplexed molecular sensing platform that couples post‐synthetically modified, emissive COF with gold‐nanostars and gene‐specific oligonucleotides to detect TS‐associated DNA. The sensing mechanism relies on a unique self‐organization of this nucleotide decorated 2D‐COF assemblies and 3D‐gold‐nanostars in presence of their target DNA sequence. This nucleotide‐driven 2D‐3D self‐organization translates molecular recognition into convergent, trimodal readouts, i.e., fluorescence, UV–Vis, and photoacoustic scattering, from a single material construct. Responses from nineteen different rare diseased samples toward the sensor platform are compared against healthy specimens. The developed sensor has been observed to quantitatively distinguish gene‐level signatures spanning SHOX, ARSE, XIST, and VAMP7, achieving limits of detection down to 5.2–61.2 pg/mL and diagnostic accuracy up to >95% for XIST when benchmarked against gold standard methods. This programmable supramolecular assembly might have the potential to become an integral part of newborn screening programs, offering early therapeutic opportunities for TS‐affected individuals.

  • A covalent organic framework-based fluorescent immunosensor for selective NGAL detection enabling diabetic kidney disease stratification

    by Satyabrata Senapati, Neethu K. M., Paresh Mohanty, Atanu Pal, Parikshit Moitra

    A covalent organic framework based fluorescent immunosensor enables rapid stratification of diabetic kidney disease with >90% sensitivity, specificity and accuracy.

  • Chronic Respiratory Diseases: Use of Quantum Particles as Nanotheranostic Agents

    by Neelam, Shefali Mallik, K. M. Neethu, Parikshit Moitra

    Chronic respiratory diseases are among the top five non‐communicable diseases (NCDs) contributing to the highest global mortality and morbidity. These diseases, which include chronic obstructive pulmonary disease (COPD), asthma, diffuse parenchymal lung disease (DPLD), lung fibrosis, and lung cancer, affect the airways and other lung structures. They can significantly impair quality of life and, if left untreated, can lead to mortality across all age groups. An effective management of chronic lung diseases therefore requires timely, accurate diagnosis and treatment. Nanotechnology based diagnosis and therapy is a growing area to address these concerns. In this context, fluorescent quantum dots with sizes of 20 nm or less are being extensively explored for their distinct photophysical properties, quantum confinement effect, potential for surface functionalization and optimum toxicity. Herein, we highlight the unique properties of QDs which make them effective tools for diagnosing chronic respiratory diseases, their potential for bioimaging applications as replacements for conventional organic fluorophores, and their therapeutic applications for respiratory diseases. Additionally, challenges associated with QDs, such as toxicity and clearance, which limit their applications are also discussed. Overall, this will be one of the first reviews which encompasses the detailed features of QDs as a nanotheranostic platform for chronic respiratory diseases. This article is categorized under: Diagnostic Tools > Biosensing Diagnostic Tools > In Vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease


  • Insights into the molecular self-assembly of urea-functionalized acetylenes

    by Neethu K M, Kritika Nag, Govindasamy Jayamurugan

    This study investigates simple acetylenes substituted with phenylurea as a constant H-bonding unit (Alk-R) and varied hydrophobic units (R = H, Phenyl (Ph), phenylacetylene (PA), Ph-NMe2) to understand self-assembly properties driven by synergistic non-covalent interactions. Our observations reveal hierarchical self-assembled fibrillar networks with luminescent needles, fibers, and flowers on nano- to micro-meter scales. Subtle changes in substituents led to significant differences: H, Ph, PA, and Ph-NMe2 produced needle-like crystals, dendritic nanofibers, microflakes, and no self-assembly, respectively. Alk-Ph-NMe2 likely did not self-assemble due to reduced hydrophobic interactions and steric hindrance. Interestingly, Alk-Ph exhibited a uniform spherulitic pattern and effectively gelled organic solvents and water. This luminescent gel demonstrated multifunctionality, including white light emission when doped with rhodamine-B dye and adsorption of organic cationic dyes (methylene blue and crystal violet) from water. This study offers valuable insights into balancing interactions to achieve desired hierarchical networks and understand material properties, guiding future molecular design.


  • Use of Quantum Dots as Nanotheranostic Agents: Emerging Applications in Rare Genetic Diseases

    by Neethu K M, Shyamal Karmakar, Baishakhi Sahoo, Navniet Mishrra, Parikshit Moitra

    Rare genetic diseases (RGDs) affect a small percentage of the global population but collectively have a substantial impact due to their diverse manifestations. Although the precise reasons behind these diseases remain unclear, roughly 80% of cases are genetically linked. Recent efforts focus on understanding pathology and developing new diagnostic and therapeutic approaches for RGDs. However, there persists a gap between fundamental research and clinical therapeutic approaches, where advancements in nanotechnology offer promising improvements. In this context, nanosized light‐emitting quantum dots (QDs), ranging from 2–10 nm, are promising materials for diverse applications. Their size‐tunable light emission, high quantum yield, and photostability allow for precise tracking of cargo. Additionally, QDs can be functionalized with therapeutic agents, antibodies, or peptides to target specific cellular pathways, enhancing treatment efficacy while minimizing side effects. By combining diagnostic and therapeutic capabilities in a single platform, QDs thus offer a versatile and powerful approach to tackle rare genetic disorders. Despite several reviews on various therapeutic applications of QDs, their utilization in the specific domain of RGDs is not well documented. This review highlight QDs’ potential in diagnosing and treating certain RGDs and addresses the challenges limiting their application.


  • A systematic study to unravel the potential of using polysaccharides based organic-nanoparticles versus hybrid-nanoparticles for pesticide delivery

    by Ritu Mahajan, Abdul Selim, K M Neethu, Sandeep Sharma, Vijayakumar Shanmugam, Govindasamy Jayamurugan

    To daze conventional pesticide release limitations, nanotechnology-mediated pesticide delivery using natural polymers has been actively investigated. However, the lack of information on what are the beneficial/non-beneficial aspects of using hybrid- and organic-nanoparticles (NP) and among the polysaccharides which are better suited concerning pesticide loading efficiency (PLE wt%), entrapment efficiency, and sustained pesticide release (SPR %) has prompted us to investigate this study. In this report, we systematically investigated a series of polysaccharides such as starch (S), cellulose (C), aminocellulose (AC), and sodium carboxymethylcellulose (NaCMC) coated on magnetite NP (MNP, Fe 3 O 4 ) and complete organic nanocarrier systems (starch and cellulose) that have no MNP part were compared for the PLE wt% and SPR % efficiencies for chlorpyrifos (ChP) insecticide. Overall, all nanocarriers (NCs) have shown good to excellent PLE wt% due to the smaller-sized NP obtained through optimal conditions. However, among the hybrid polysaccharides studied, starch MNP has shown a maximum PLE of 111 wt% in comparison with other polysaccharides (80–94 wt%) coated hybrid-NCs as well as with organic-NCs (81–87 wt%). The use of inorganic support does improve the PLE wt% markedly for starch but not for cellulose derivatives. Similarly, the SPR results of S-NP showed a remarkably better sustained release profile for ChP of 88% in 14 d. In contrast, other unfunctionalized and functionalized celluloses exhibited poor release profiles of 60%–20% for the same period. This study may help the researchers choose the right system for designing and achieving enhanced pesticide efficiency.


  • Tuning of cross-Glaser products mediated by substrate–catalyst polymeric backbone interactions

    by Sharanjeet Kaur, Aritra Mukhopadhyaya, Abdul Selim, Vijayendran Gowri, K. M. Neethu, Arif Hassan Dar, Shaifali Sartaliya, Md. Ehesan Ali, Govindasamy Jayamurugan

    Tuneable selectivity in cross-Glaser products is achieved by tweaking the catalyst-backbone. The interaction responsible for this is unravelled.